Opsonophagocytic Killing Antibody toPseudomonas aeruginosaMucoid Exopolysaccharide in Older Noncolonized Patients with Cystic Fibrosis
- 24 September 1987
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 317 (13) , 793-798
- https://doi.org/10.1056/nejm198709243171303
Abstract
The principal cause of morbidity and mortality in cystic fibrosis is persistent respiratory colonization with mucoid strains of Pseudomonas aeruginosa. To investigate possible mechanisms of resistance to this organism, we studied serum from 16 older (≥12 years) patients not colonized with mucoid P. aeruginosa, 11 older (≥14 years) colonized patients, 10 younger (≤11 years) noncolonized patients, and 20 healthy adults.This publication has 20 references indexed in Scilit:
- ALTERNATE-DAY PREDNISONE REDUCES MORBIDITY AND IMPROVES PULMONARY FUNCTION IN CYSTIC FIBROSISThe Lancet, 1985
- Antibody to Pseudomonas Aeruginosa Mucoid Exopolysaccharide and to Sodium Alginate in Cystic Fibrosis SerumPediatric Research, 1984
- Granulocyte Neutral Proteases and Pseudomonas Elastase as Possible Causes of Airway Damage in Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1984
- Quantitation and Identification of Antibodies to Outer-Membrane Proteins of Pseudomonas aeruginosa in Sera of Patients with Cystic FibrosisThe Journal of Infectious Diseases, 1984
- IMMUNE COMPLEX MEDIATED TISSUE DAMAGE IN THE LUNGS OF CYSTIC FIBROSIS PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA INFECTIONActa Paediatrica, 1982
- CYSTIC FIBROSISMedicine, 1977
- Human Immunity to Pseudomonas aeruginosa. II. Relationship between Heat-Stable Opsonins and Type-Specific LipopolysaccharidesThe Journal of Infectious Diseases, 1972
- A new modification of the carbazole analysis: Application to heteropolysaccharidesAnalytical Biochemistry, 1968